Hologic, Inc.
WHO'M
ai
Digital Profiler. Simply click the AI button
FIGI: BBG000C3NTN5
HOLX
Hologic, Inc.
GICS: 35101010
·
Sector: Healthcare
·
Sub-Sector: Medical Instruments & Supplies
NAME
Hologic, Inc.
ISIN
US4364401012
TICKER
HOLX
MIC
XNAS
REUTERS
HOLX.OQ
BLOOMBERG
HOLX US
F&G:
61
Financial Intelligence
FOR INVESTORS
FOR TRADERS
Securities Trading
The X-News Explorer is the ultimate source of information for investors with an affinity for the stock market who want to get a quick and convenient overview of the current news situation of a listed company. Various newswire services are available to you here. If a news alert is displayed, you will find company news that may be of interest to you. This service is provided by BusinessWire.
Thu, 22.05.2025
Hologic
US4364401012
Hologic, Inc. (Nasdaq: HOLX) and its subsidiary, Biotheranostics, Inc., today announced new data demonstrating the significant clinical impact of the Breast Cancer Index® (BCI®) test, which will be presented at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting on June 2, 2025.
“These data highlight the critical role the Breast ...
Hologic
Tue, 13.05.2025
Hologic
US4364401012
Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at the following upcoming investor conferences:
The 2025 RBC Capital Markets Global Healthcare Conference in New York on Tuesday, May 20 at 9:30 a.m. Eastern Time (ET) in New York.
William Blair’s 45th Annual Growth Stock Conference in Chicago on Wednesday, June 4 at 4 ...
Hologic
Thu, 01.05.2025
Hologic
US4364401012
Hologic, Inc. (Nasdaq: HOLX) announced today the Company’s financial results for the fiscal second quarter ended March 29, 2025.
“We delivered on our financial commitments in the second quarter,” said Stephen P. MacMillan, the Company’s Chairman, President and Chief Executive Officer. “Both revenue and non-GAAP EPS finished at the high ends of ou...
Hologic
Thu, 24.04.2025
Hologic
US4364401012
Hologic, Inc. (Nasdaq: HOLX) will have a strong presence at the Society of Breast Imaging (SBI) Annual Symposium in Colorado Springs, Colorado this week, including the presentation of pivotal new research conducted by a top-tier healthcare facility focused on the company’s AI-driven mammography technology.
This press release features multimedia. V...
Hologic
Tue, 22.04.2025
Hologic
US4364401012
Hologic, Inc. (Nasdaq: HOLX), a company that develops industry-leading technologies that detect, diagnose and treat life-changing health conditions that affect women, today released its annual sustainability report with an emphasis on expanded environmental commitments and efforts to advance access and equity in women’s health.
This press release ...
Hologic
Fri, 04.04.2025
Hologic
US4364401012
Hologic, Inc. (Nasdaq: HOLX) announced today that Wayde McMillan has been elected to the Company’s Board of Directors, effective April 4, 2025. Mr. McMillan was also appointed to the Audit and Finance Committee effective April 4, 2025.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/202504...
Hologic
Thu, 03.04.2025
Hologic
US4364401012
Hologic, Inc. (Nasdaq: HOLX) announced today that the Company plans to release its financial results for the second quarter of fiscal 2025 on Thursday, May 1, after the market closes. In conjunction with the release, management will host a conference call that day at 4:30 p.m. Eastern Time.
Interested participants may listen to the call by dialin...
Hologic
Tue, 25.02.2025
Hologic
US4364401012
Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at the Raymond James & Associates' 46th Annual Institutional Investors Conference on Tuesday, March 4 at 11 a.m. Eastern Time (ET).
The presentation will be webcast live and may be accessed through a link on the investors section of Hologic’s website at http://investor...
Hologic
Thu, 20.02.2025
Hologic
US4364401012
Global women’s health leader Hologic, Inc. (Nasdaq: HOLX) today announced that its Affirm® Contrast Biopsy Software, which combines contrast-enhanced diagnostic capabilities with accurate lesion targeting to help streamline workflow and accelerate biopsy procedures,1-2 is now CE-marked. The technology received clearance from the U.S. Food and Drug...
Hologic
Tue, 18.02.2025
Hologic
US4364401012
Hologic, Inc. (Nasdaq: HOLX) announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company’s Aptima® SARS-CoV-2 assay, which was first granted Emergency Use Authorization (EUA) status in May 2020.
“Our COVID test was instrumental in addressing critical testing needs during the pandemic and offered h...
Hologic
Information on product placements
SMART * AD
P R O D U C T S U G G E S T I O N S
